Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio-Techne (TECH) Interest Expenses (2016 - 2026)

Bio-Techne has reported Interest Expenses over the past 12 years, most recently at $2.2 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 1.07% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $9.3 million, down 14.28%, while the annual FY2025 figure was $8.5 million, 45.93% down from the prior year.
  • Interest Expenses for Q4 2025 was $2.2 million at Bio-Techne, down from $2.9 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $4.9 million in Q3 2023 and troughed at $1.4 million in Q1 2023.
  • A 5-year average of $2.9 million and a median of $2.6 million in 2021 define the central range for Interest Expenses.
  • On a YoY basis, Interest Expenses climbed as much as 192.98% in 2024 and fell as far as 55.53% in 2024.
  • Year by year, Interest Expenses stood at $2.9 million in 2021, then decreased by 18.81% to $2.4 million in 2022, then surged by 83.74% to $4.3 million in 2023, then plummeted by 50.38% to $2.1 million in 2024, then grew by 1.07% to $2.2 million in 2025.
  • Business Quant data shows Interest Expenses for TECH at $2.2 million in Q4 2025, $2.9 million in Q3 2025, and $2.2 million in Q2 2025.